[{"Assets_0_Q2_USD":96971000.0,"CommonStockSharesOutstanding_0_Q2_shares":16217735.0,"NetIncomeLoss_1_Q2_USD":-10158000.0,"NetIncomeLoss_2_Q2_USD":-16091000.0,"StockholdersEquity_0_Q2_USD":67610000.0,"Ticker":"GEVO","CIK":"1392380","name":"GEVO, INC.","OfficialName":"Gevo Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"886730226.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]